All

Putting Your Mask on First


When on an airplane, the flight attendant procedurally says something like, “If oxygen masks release and you are traveling with a child, please secure your own mask first before assisting others.” Historically my thoughts were, “Wait, WHAT?!? You think I am going to selfishly put my mask on first when I could save my child? You’re crazy!” 


That was until I experienced my first signs of caregiver burnout. The frustration, anxiety, and difficulties with my own health became more prevalent, and I became, at times, unable to physically or emotionally care for my own child with a medical condition. It was at this point I learned the healthier I am, the better, more attentive, and more capable parent I can be.

 Why did it take so long to figure this out? The fear of being a “burnout” or something other than a superhero, was overwhelming. The fear someone else might not care for my child the way I would, or that I would miss something if I took a moment for myself was overwhelming. Any parent who has skipped taking a shower, slept on a child’s floor, or forgotten to eat because they were too busy taking care of their child, knows EXACTLY what I am talking about… these pointers are for you! 

Telltale signs and symptoms of caregiver stress that may lead to burnout include:

  • Feeling tired

  • Anxiety, depression, irritability

  • Trouble sleeping

  • Increased personal health problems

  • Difficulty concentrating

  • Feeling overwhelmed or without adequate support while caring for your loved one


Methods to Help Mitigate Burnout

Practice stress-reduction strategies, such as meditation or stretching

Get as much rest as possible… naps are acceptable!

Maintain a routine including nutritious meals, and assign yourself a regular bedtime

Exercise—even if that means parking a bit further from your destination, walking will get your blood flowing. Exercise can also combat depression. Try to exercise at least 10 minutes a day.

Schedule time off from care giving. Don’t be afraid to ask for help from a family member, friend, or neighbor. It’s healthy to take a break, if even for just a few moments.

Reach out for support to help you with your feelings. Talk to your medical provider, family member, trusted friend, or a counselor. Many communities have support groups for caregivers as well.

Remember, you must care for yourself in order to care for someone else. There is nothing selfish about caring for your own health.


BioMatrix Specialty Pharmacy offers exceptional service and support for patients requiring infused or injectable medications.

Our tailored approach for a broad range of therapeutic categories helps improve quality of life for patients while producing positive outcomes along the entire healthcare continuum.  

Through individualized specialty pharmacy services, timely access to care, and focused education and support, we are making a difference in the communities we serve, one patient at a time.


To learn more about the therapies we serve, click below:


DISCLAIMER: THIS IS NOT MEDICAL ADVICE. All information, content, and material is for informational purposes only and is not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider. Please consult a physician or other health care professional for your specific health care and/or medical needs or concerns and never disregard professional medical advice or delay in seeking it because of something you have read here or on our website.


Stay informed on the latest trends in healthcare and specialty pharmacy.

Sign up for our monthly e-newsletter, BioMatrix Abstract.

By giving us your contact information and signing up to receive this content, you'll also be receiving marketing materials by email. You can unsubscribe at any time. We value your privacy. Our mailing list is private and will never be sold or shared with a third party. Review our Privacy Policy here.


Lambert-Eaton Myasthenic Syndrome (LEMS): Signs, Symptoms, and Treatment Options


With an estimated 400 known cases in the U.S.1, Lambert-Eaton Myasthenic Syndrome (LEMS) is a rare, autoimmune, neurological disorder in which the body's immune system attacks its own tissues. With LEMS, the body specifically attacks the neuromuscular junction—i.e. the connections between nerves and muscles. This causes weakness in the upper legs, hips, upper arms, and shoulders. Both walking and self-care can be difficult.

More than 50% of LEMS cases happen in middle aged or older people, with symptoms often occurring prior to the diagnosis of lung cancer.2 Because cancer cells share some of the same proteins as nerve endings, it’s thought that the body attacks nerve endings in an attempt to kill cancer cells. In the other half of LEMS cases, the cause is unknown and typically occurs around age 35.


Signs and Symptoms

LEMS is characterized by weakness starting in the legs and hips, progressing to the arms and shoulders. Onset of signs and symptoms is typically gradual. Additional signs and symptoms may include:

  • Muscle aches

  • Muscle weakness that gets worse with time

  • Fatigue

  • Difficulty walking and climbing stairs

  • Difficulty lifting objects and raising arms

  • Drooping eyelids

  • Dry eyes

  • Dry mouth

  • Blurred vision

  • Difficulty swallowing

  • Dizziness upon standing

  • Constipation

  • Erectile dysfunction

It’s important to note that because of similar symptoms of muscle weakness, LEMS is often misdiagnosed as Myasthenia gravis (MG). However key differences are in the severity and type of muscle weakness. For example, eye weakness tends to be milder in LEMS patients and unlike MG, is typically not the only symptom. Severe respiratory muscle weakness found in MG is also rare for people with LEMS.


Treatment Options

Although there is no cure for LEMS, treatment can help relieve and lessen symptoms. If LEMS is connected to a cancer diagnosis, treatment is first targeted at the cancer which may then greatly improve LEMS symptoms.

Medicines to help nerve signals reach the muscles as well as immunosuppressants (like steroids) can help relieve symptoms. If symptoms are advancing and other treatments have not helped, both plasmapheresis (plasma exchange) and intravenous immunoglobulin (IVIG) are used to treat LEMS. 

Plasmapheresis redirects blood through a machine which filters out the antibodies attacking the nerves. IVIG, which is immunoglobulin given intravenously or through a vein, suppresses the inflammatory response. Derived from thousands of healthy blood plasma donations, immunoglobulin therapy can help suppress an overactive immune system by preventing it from attacking healthy cells.


Helpful Resources

The Muscular Dystrophy Association provides support, education, care, and advocacy for patients with neuromuscular diseases, like LEMS, and their families and/or caretakers. Some of these resources include: 

Community resources like access to transportation, clinical trials finder tool, and equipment assistance


How BioMatrix Can Help

Though an LEMS diagnosis can feel overwhelming for you or a loved one, it’s important to know that you are not alone. Organizations like the Muscular Dystrophy Association mentioned above can provide a wealth of information and support as well as connect you to others in the community who have experienced the same diagnosis as well as others with neuromuscular conditions. In addition, your specialty pharmacy can offer individualized support to help manage treatment.

BioMatrix helps manage the individual needs of patients requiring IVIG therapy. Knowledgeable pharmacists and care coordination staff guide each patient through the potential medication side effects and, working with the prescribing physician, help manage treatment to reduce the prevalence and severity of symptoms.

The BioMatrix clinical team includes compassionate nurses who have extensive training and experience with rare diseases, infusion therapies, and complex medical conditions. Our nurses work together with patients, caregivers, pharmacists, and prescribers to coordinate the optimal site of care, conduct nursing interventions, and provide patient education.


Learn more about how our individualized specialty pharmacy services for patients with LEMS and other neurological and neuromuscular conditions.


DISCLAIMER: THIS IS NOT MEDICAL ADVICE. All information, content, and material is for informational purposes only and is not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider. Please consult a physician or other health care professional for your specific health care and/or medical needs or concerns and never disregard professional medical advice or delay in seeking it because of something you have read here or on our website.


Stay informed on the latest trends in healthcare and specialty pharmacy.

Sign up for our monthly e-newsletter, BioMatrix Abstract.

By giving us your contact information and signing up to receive this content, you'll also be receiving marketing materials by email. You can unsubscribe at any time. We value your privacy. Our mailing list is private and will never be sold or shared with a third party. Review our Privacy Policy here.


References

  1. (2019). Lambert-Eaton Myasthenic Syndrome. National Organization for Rare Disorders (NORD). https://rarediseases.org/rare-diseases/lambert-eaton-myasthenic-syndrome/

  2. (2023). Jayarangaiah A, Theetha Kariyanna P. Lambert-Eaton Myasthenic Syndrome. National Library of Medicine (NIH). https://www.ncbi.nlm.nih.gov/books/NBK507891/


The Coalition for Hemophilia B 17th Annual Symposium

By Michelle Stielper and Tina McMullen


It really is SO fantastic to “B” together as no event encapsulates this feeling more every year than The Coalition for Hemophilia B Symposium. The 17th Annual Symposium took place March 16th–19th at the Renaissance Orlando at SeaWorld. The Coalition team pulls out all the stops when it comes to making an event feel like a family reunion. New families are embraced from the start and quickly find a home among their fellow hemophilia B community members.


Programming offered something for everyone from the young to the young at heart; Tai Chi classes, massages, medical talks, programming discussing emerging therapies, and men’s and women’s breakout sessions all brought the B community together while programming for the youngsters and teens was pure magic. New friends were made, and existing friendships were nourished and flourished as the kids got crafty, had their face painted, made origami, hung out in the teen lounge, or went offsite for an airboat ride at Wild Florida Airboats, Gator and Safari Park.

BioMatrix Regional Care Coordinator, Shelia Biljes, led two sewing sessions co-sponsored by Medexus Pharma. Participants - pure beginners and master sewers alike - were welcome to share their personal journeys as they quilted beautiful tote bags as a keepsake of their special time together. Christian Harris, our B community fashion designer extraordinaire and Medexus speaker, discussed his path through the fashion industry, and how he created a line of clothing inspired by his personal journey with a bleeding disorder. The finished B bags Shelia helped participants make were marvelous, and everyone did a sensational job!

The entire event was energy-filled and buzzing with activity, and the BioMatrix booth was a busy beehive. BioMatrix Director of Advocacy and Education, Terry Rice, emceed rousing rounds of Jeopardy in a battle of points between the guys and the gals. The gals won last year; the guys won this year. Prepare for a 2024 tie breaker!

At the booth we had information about our newly launched Patient Navigation Program, which can provide valuable assistance for families facing insurance obstacles and financial challenges to care. In addition to offering different promo items each day, we held raffles at the booth for a treasure chest gift basket and a beautiful, quilted table runner (thank you, Shelia!) to complement the bee-themed tote bag. Congratulations to our raffle winners!

We cannot forget to tell everyone about the final night party – a fabulous time spent making wonderful memories! The Bleeders band, featuring BioMatrix’s very own “Doc of Rock” Shelby Smoak, played great tunes and brought the house down during dinner. Dancing and singing ringing throughout the evening in the atrium of the Renaissance. Everyone had a blast spending one last night together before heading home. It’s always hard to say goodbye to our dear B’s, but here’s to another year! Before we know it, we will B together again!


Stay informed on the latest trends in healthcare and specialty pharmacy.

Sign up for our monthly e-newsletter, BioMatrix Abstract.

By giving us your contact information and signing up to receive this content, you'll also be receiving marketing materials by email. You can unsubscribe at any time. We value your privacy. Our mailing list is private and will never be sold or shared with a third party. Review our Privacy Policy here.


NHF Washington Days Advocating on the Hill


Advocates in the bleeding disorders community descended upon our nation’s capital March 8–10 to create awareness and press for better legislation against copay accumulator adjustors. This was part of the National Hemophilia Foundation’s Washington Days, an event which had stalled during COVID and was virtual in 2022. This was the first full return of face-to-face advocacy with Congress in several years.


A top advocacy issue this year involved asking House Members to cosponsor H.R. 830, the HELP Copays Act. This act would require all copays (regardless of who contributes) to count towards a person’s out-of-pocket maximum. Sixteen states and Puerto Rico currently have laws restricting an insurer’s use of a copay accumulator adjustor, a policy where dollars provided by a third-party source (such as a manufacturer drug copay card) do not apply toward a patient’s out-of-pocket amount. However, those laws only protect patients on those state’s plans. The legislation would offer protection for people on employer–sponsored retirement and health plans, also known as ERISA plans, or large group plans.

Another advocacy issue included asking for continued funding of programs supported through NIH, CDC, and HRSA. NIH (The National Institutes of Health) is currently investigating the rise of inhibitors within the bleeding disorders community; the CDC (Centers for Disease Control and Prevention) provides funding to HTCs (Hemophilia Treatment Centers) for outreach and education; and HRSA (Health Resources and Services Administration) supports ancillary services within the HTC setting like physical therapy and social work. A reduction of these funds would negatively impact the current level of care persons with a bleeding disorder receive and would have consequences in the future as inhibitors and other issues become understudied.

After NHF training and a role-playing exercise to demonstrate the “Do’s and Don’ts” of meeting with elected officials, the advocates felt prepared. The Advocacy Day began with a speech from Representative Earl “Buddy” Carter (R-GA-01) who is sponsoring H.R. 830, the bill the group was there to support. With his words of encouragement, the advocates headed out to descend upon the Capitol and meet with elected officials. Several BioMatrix members were there to support the advocacy efforts.

Richard Vogel with Team New Jersey was busy with five Congressional meetings. Starting with a visit to the office of Senator Robert Menendez (D-NJ), advocates seamlessly interwove their stories into a cohesive narrative which started with the younger generation, moved on to women with bleeding disorders, and then concluded with those who have reached retirement age. New Jersey was fortunate to have with them for their advocacy Stephanie Lapidow, Executive Director and Amy LaPorta, Office Manager of Hemophilia Association of New Jersey.

Senator Menendez has been very supportive of bleeding disorder issues in the past; he sponsored the Hemophilia Skilled Nursing Facilities Access Act (H.R. 5952, 116th Congress). Team New Jersey is hopeful he will introduce the companion legislation to the HELP Copays Act in the Senate, another bipartisan bill.

The team next went to the office of Senator Cory Booker (D-NJ). On the House side, the team met with Representatives Josh Gottheimer (D-NJ 05), Mikie Sherrill (D-NJ-11), and Bonnie Watson-Coleman (D-NJ-12), the latter already a cosponsor of H.R. 830. In their offices, the legislative aides expressed empathy and interest in supporting the cause.

For the full Capitol experience, the team was lucky enough to get passes to the House Gallery where they were able to watch democracy in action.

Shelby Smoak attended as an advocate for Virginia. He and Brenda Bordelon, fellow constituent and Chapter Director of Hemophilia Association of the Capitol Area, met with Representative Ben Cline (R-VA-06). The meeting was spirited, and Representative Cline seemed especially interested in H.R. 830 and the CDC funding, the latter of direct importance since he sits on the House Appropriations Committee which is responsible for making funding determinations.

Representatives Rob Wittman (R-VA-01) and Morgan Griffith (R-VA-09) made time for staff to hear stories from the community and were asked to support our cause. On the Senate side, the offices of both Virginia Senators Tim Kaine (D-VA) and Mark Warner (D-VA) were receptive to the financial burdens endured by the community as explained by our group. They both took pride in being Senators from the state which was the very first to pass a copay accumulator ban.

Felix Jaquez Garcia from New Mexico, teamed up with members from Puerto Rico to support them at their meeting with Representative Jenniffer González-Colón (R) of Puerto Rico. She was very receptive and immediately jumped in to work with the Puerto Rico chapter to protect access to HTCs.

In his meeting with Senator Ben Ray Luján’s (D-NM) staff, Felix was optimistic the Senator would sign on as a cosponsor to ban copay accumulators should a bill be introduced. Felix also connected with the staffer from Senator Heinrich’s (D-NM) office, who also was willing to support a copay accumulator ban.

In the office of Representative Gabriel Vasquez (D-NM-02), the meeting with his staffer was productive as well as they were in support of the NHF initiatives.

Justin Lindhorst and Dave Burgeson attended from the state of Florida. Team Florida included nine advocates determined to help lawmakers understand the unique needs of the bleeding disorders community. While all five offices visited listened attentively to the concerns, the greatest victory came when meeting with Representative Bill Posey (R-FL-08). Rep. Posey was so inspired by the story shared by his constituents, he agreed on the spot to support H.R. 830 as a cosponsor. Congratulations to advocates Heather and Samantha for so eloquently sharing their story and securing support for the HELP Copays Act.

Terry Rice and two other constituents from Maine added their numbers to a larger New England contingency and made numerous congressional visits. Their first home state visit was with Senator Susan Collins (R-ME). Senator Collins listened to the concerns regarding access to affordable lifesaving prescriptions and the effect copay accumulators are having on patients and families living with a chronic illness that must be treated with expensive name brand medications that have no generic alternatives. She was supportive in finding a solution to deal with the accumulator adjustors, which have been crippling the financial and physical health of affected individuals and asked to be kept informed with the progress of H.R. 830 should a Senate companion bill be introduced. As the Ranking Member on the Senate Appropriations Committee, Senator Collins expressed support to continue HRSA and CDC funding of HTCs.

The team also met with Senator Angus King’s (I-ME) office. Senator King’s legislative assistant shared he has type-1 diabetes and was very aware of the detrimental effects of accumulator adjustors. He felt the Senator would support legislation to address the issue and was confident he would continue to support HTC level funding.

On the House side, the team left information with Representative Jared Golden (D-ME-02) and were able to meet with the legislative health aide to Representative Chellie Pingree (D-ME-01) who cosponsored accumulator adjustor legislation in previous years and would again cosponsor H.R. 830. The aide assured Representative Pingree would support continued HTC funding.

The meetings with the House and Senate offices set in motion the narrative of the burden our bleeding disorders community bears: financially, mentally, and necessarily, physically. To all the advocates from the nearly 50 states who joined the advocacy efforts, we say thank you! And to NHF, we also say thank you for organizing this energy on the Hill and aiding the community voices to be heard.

As nuanced as everyone’s experience is of living with hemophilia, von Willebrand, or another factor deficiency – people with a bleeding disorder endure the costs of medications and the need for the protection H.R. 830 would grant; and even if not seen at an HTC, everyone benefits from the funding and support granted by our national institutions: NIH, CDC, and HRSA.

Real change has come from the efforts of NHF Washington Days Advocacy and hopefully, community members who shared their stories this year will impact further positive changes for the bleeding disorders community.


Stay informed on the latest trends in healthcare and specialty pharmacy.

Sign up for our monthly e-newsletter, BioMatrix Abstract.

By giving us your contact information and signing up to receive this content, you'll also be receiving marketing materials by email. You can unsubscribe at any time. We value your privacy. Our mailing list is private and will never be sold or shared with a third party. Review our Privacy Policy here.


Camp Warren Jyrch Celebrates 50 Years!

By John Thorson – Longtime Camp Volunteer


Bleeding Disorders Alliance Illinois Camp Warren Jyrch (CWJ) is celebrating a golden anniversary! Fifty years of summer camp began in 1973 when at the time, the Illinois chapter went by the name of Hemophilia Foundation of Illinois. The camp was named to honor Warren C. Jyrch (1921-1971) of Chicago, the first person with hemophilia to undergo and survive open-heart surgery to replace a valve. The surgery was extremely risky with 2400 pints of blood used during the operation.


Through the years, there have been a lot of changes, but many things have remained constant. One area that has seen changes in the past 50 years is the variety of treatment options. Back then, patients spent a significant time in hospitals recovering from bleeding episodes and orthopedic issues. They missed a lot of school and opportunities to bond with other kids. For some young patients, their primary friendships were with hospital staff.

Today’s medical advancements and treatment options allow kids with a bleeding disorder to rarely miss school. Most often, they can participate in all sorts of physical activities like rock climbing, cycling, running, and sports such as baseball, basketball and volleyball, to name a few.

Fifty years ago, communication with affected families was through a tethered phone line or a stamped letter. It wasn’t always easy to make announcements about camp or request information from families. Even getting to camp involved maps and directions rather than an address easily plugged into a GPS. Today our ability to communicate is instant and helps to offer a more positive outlook on managing a bleeding disorder.

In those times, only boys were thought to have hemophilia. Girls were not invited to camp. Siblings weren’t invited either. Today we have a better understanding of how girls are affected by bleeding disorders, especially as more than carriers, and are now included. We also better understand how a bleeding disorder diagnosis affects the whole family, so siblings are also invited to share the camp experience.

Despite the challenges of those days, it was deemed important enough to gather this group of young patients for a week every summer with the purpose of socializing, bonding, and feeling less isolated with their medical conditions. And so CWJ was started. Over the years, we have learned to overcome obstacles and have adapted to many changes. We continue to look toward the future and move forward.

Camp was founded to give boys with hemophilia an opportunity to be with others just like them—to talk, laugh, try new things, support each other, bond, and just be! At its inception, the mission was to encompass a safe and fun environment, encourage peer relationships, and increase self-confidence and independence.

Although many changes have been implemented along the way, the mission of camp remains the same—to encompass a safe and fun environment, encourage peer relationships, and increase self-confidence and independence. Plenty of education has been added. Kids learn more about managing their disorder and camp is where many first learn to self-infuse.

 The first time I volunteered at camp was in 2009. I wanted to bring energy and inspiration, and be a mentor. I also wanted to gain an understanding of what kids with a bleeding disorder deal with and why camp is magical to them. By offering a safe environment and gentle suggestions, camp helps kids think differently, allowing them to go outside their comfort zones to try new activities and learn and share with one another without judgment. 

I want to leave a legacy of having done the best I could to help kids develop and reach whatever goals they set for themselves. The good stuff is when a camp activity applies to life at home, and a camper declares, “I never thought I could, but I can, and I did!” Watching a child grow to adulthood and graduate from being a camper to a counselor is especially rewarding.

On their 50th anniversary, we thank the CWJ pioneers who paved the way with such bravery for future generations of camp goers! We celebrate every attendee, family, caregiver, medical staff, and volunteer who has been associated with the success of Camp Warren Jyrch!

With gratitude and appreciation, I am glad to have been a part of it!


Stay informed on the latest trends in healthcare and specialty pharmacy.

Sign up for our monthly e-newsletter, BioMatrix Abstract.

By giving us your contact information and signing up to receive this content, you'll also be receiving marketing materials by email. You can unsubscribe at any time. We value your privacy. Our mailing list is private and will never be sold or shared with a third party. Review our Privacy Policy here.


What It Means to Be Part of the BioMatrix Family


In a large study, patients who perceived their healthcare providers as “knowing them as a person” had higher rates of treatment adherence, more positive beliefs about the effectiveness of their therapy, fewer missed doctor appointments, and a higher quality of life.1

While this is a great starting point for patient care, our BioMatrix team is committed to going beyond perception. We are committed to building authentic relationships with our patients that support their overall wellbeing. It’s part of our mission and engrained in who we are. Our patients are like family. This means having compassion for our patients. It means being available to our patients. It means caring for our patients and their families beyond treatment. It also means advocating for our patients.


We have compassion for our patients and want to see them live life to the fullest. 

We believe that a strong relationship between a patient and their healthcare provider can positively affect a patient’s ability to cope and have more positive health outcomes. Pharmacists and pharmacy staff who take the time with each patient to understand needs, challenges, and preferences are better positioned to support, educate, and serve. We believe this is what sets Biomatrix apart. Our team invests in our patients on an individual level.

“I love working with the bleeding disorders community. Being a pharmacist is much more than just dispensing medication to a patient. It is an opportunity to build relationships and leverage my knowledge and skills to guide patients through their treatment goals, reduce breakthrough bleeding, and improve quality of life. It’s all about helping people achieve better health.”

– Kimberly Epps PharmD, CSP | Vice President of Infusion Pharmacy Services


“I am committed to helping patients on their journey to better health. My biggest priority is providing peace of mind while focusing on making a difference for others.”

– Charlotte Prohaska, RN, National Director of Transplant


“Healthcare is my calling. Knowing my work can positively impact a patient’s life is an incredible feeling. Coordinating services, facilitating patient support, advancing clinical trials, and working to break down barriers to care is what I believe in and is what I’m honored to do.”

– Stacy Shillan, National Director, Neurology and Immunology


From the time medication is prescribed, we’re available to our patients throughout their entire treatment journey.

From the initial prescribed treatment, our new patients will receive an introductory phone call from BioMatrix within 24 hours or less. Our Referral Specialists make sure our patients feel welcomed by providing a New Patient Welcome Packet and helping our patients with the insurance verification and approval process. The Referral Specialist then helps connect the patient with financial support resources (if needed), conducts a patient start-of-care assessment, and schedules therapy delivery with the patient. From there, a patient is connected with a dedicated Patient Support Specialist who assesses for side effects and adherence throughout treatment. Patient Support Specialists are available to patients for questions and support 24/7 and are truly dedicated to listening, encouraging, and caring for patients as individuals.


We care about our patient’s well being—beyond dispensing medication.

We provide a full spectrum of patient and caregiver support. Through educational programs, we empower our patients on topics like health insurance, accommodations in the academic setting, how to avoid caregiver burnout, coping with the stress of having a chronic condition, and so much more. Our education team is uniquely qualified to offer these programs that help navigate the ups and downs of life with a chronic condition.


We advocate for our patients.

Our job is to help our patients obtain and maintain access to prescribed therapy. We ensure our patients understand their specialty medication insurance coverage, how to get their medication in a timely manner, and what financial support options are available. From therapy initiation, payer outreach, benefit investigation, prior authorization, appeals management, and connectivity to manufacturer patient access services, we coordinate care between all healthcare providers to help our patients promptly begin and maintain access to their medication. We also make sure patients understand how to properly store medications, how to take it, and who to contact when they have questions.

In addition, many of our BioMatrix team members are committed to advocating for the patient communities we serve on a national level. Partnerships with non-profit organizations for scholarships, community events, and annual meetings are also ways that we support our patients on a personal level and engage with important topics facing those with chronic conditions.


In summary, our patients are like family to us, which means that treatment success goes beyond dispensing medication. We have compassion for our patients and want to see them live life to the fullest. We're available to our patients for the duration of their treatment, positioning resources and support to make managing complex therapies easier. We care about our patient’s overall well being. We also advocate for our patients. This is what it means to be part of the BioMatrix family.


BioMatrix Specialty Pharmacy offers exceptional service and support for patients requiring infused or injectable medications.

Our tailored approach for a broad range of therapeutic categories helps improve quality of life for patients while producing positive outcomes along the entire healthcare continuum.  

Through individualized specialty pharmacy services, timely access to care, and focused education and support, we are making a difference in the communities we serve, one patient at a time.


To learn more about the therapies we serve, click below:


Stay informed on the latest trends in healthcare and specialty pharmacy.

Sign up for our monthly e-newsletter, BioMatrix Abstract.

By giving us your contact information and signing up to receive this content, you'll also be receiving marketing materials by email. You can unsubscribe at any time. We value your privacy. Our mailing list is private and will never be sold or shared with a third party. Review our Privacy Policy here.


References

  1. Beach MC, Keruly J, Moore RD. Is the quality of the patient-provider relationship associated with better adherence and health outcomes for patients with HIV? J Gen Intern Med. 2006;21(6):661-665. doi:10.1111/j.1525-1497.2006.00399.x


Men’s Health Week


In the week leading up to Father’s Day, Men’s Health Week encourages boys, men, and their families to check in with their health.

In addition to encouraging overall health and well-being, Men’s Health Week encourages screening for common diseases among men that can be prevented, treated and/or cured if caught early. Here we outline some important screenings to schedule, disease prevention tips, and health concerns to discuss with your doctor.


Kidney Health

Your kidneys perform many critical functions in your body. They help remove waste and excess fluid removal, filter the blood, and help regulate blood pressure and the amount of certain nutrients in the body.1 When your kidneys start to lose function, you may be diagnosed with chronic kidney disease (CKD). CKD can be caused by diabetes and high blood pressure, among other disorders. Loss of kidney function can lead to kidney failure, which requires either dialysis or a kidney transplant to stay alive.2 1 in 3 adults are at risk for kidney disease. Though women are more likely to develop kidney disease, kidney failure is more common in men.3

By exercising regularly, controlling your weight, eating a healthy diet, staying hydrated, not smoking, and limiting alcohol, you can help keep your kidneys healthy. Early detection of kidney disease is also key. Be sure to get your annual medical exams. Discuss your kidney disease risk with your doctor in order for them to determine any necessary tests or additional screening/treatment measures.3


Neurological Disorders

Neurological disorders such as multiple sclerosis, Alzheimer's, and Parkinson are on the rise.4 While each neurological condition has its own set of characterizing symptoms, common symptoms include:

  • Sudden onset of headaches
  • Muscle weakness
  • Loss of feeling and tingling
  • Double vision
  • Lack of coordination

If you are having any of these symptoms, schedule an appointment with your doctor. While there is no cure for many neurological disorders, early diagnosis, treatment, and self care can often keep symptoms manageable and slow disease progression.


Autoimmune Disorders

It’s estimated that roughly 8% of people in the U.S. have an autoimmune disorder.5 Autoimmune disorders happen when your immune system mistakenly attacks healthy cells in your body. This causes inflammation in the body, though the symptoms can look different depending on the type of autoimmune disorder. Affecting up to 1% of the U.S. population6, Rheumatoid Arthritis (RA) is one of the most common autoimmune disorders that causes inflammation in joints such as hands, wrists, elbows, feet, ankles, and knees.

Similar to neurological disorders, there is often no cure for autoimmune disorders. However, early diagnosis, treatment, and self care may help slow disease progression while supporting a more active lifestyle. Schedule an appointment with your doctor if you’re experiencing symptoms of inflammation including joint pain, swelling in parts of the body, skin rashes, and/or fevers that come and go.


Heart Disease Prevention

The leading cause of death for men in the U.S. is heart disease.7 Symptoms include chest pain, tightness, and/or pressure; shortness of breath; pain, numbness, weakness, and/or coldness in legs and/or arms; and pain in the neck, jaw, throat, upper abdomen, and/or back. Men are more likely than women to have chest pain.8 Sometimes heart disease isn’t diagnosed until it’s too late. Diabetes, being overweight, a poor diet, not exercising, and excessive alcohol consumption all increase the risk for heart disease.7 To help prevent heart disease and its complications, get your routine medical exams. Know your blood pressure, and ask your doctor if you should be tested for diabetes. Make healthy diet choices, exercise, limit alcohol consumption, and find healthy ways to lower your stress levels.7


Cancer Screenings & Prevention

Many of the most common types of cancer diagnoses for men are treatable and curable if caught early.

Skin cancer. Schedule a ‘skin check’ with a dermatologist, and follow their recommendations for the frequency of followup visits.9

Prostate cancer. Blood tests and certain types of exams can detect prostate cancer before symptoms appear.10 According to the American Cancer Society, the discussion about screening should take place at age 50 for men at average risk, age 45 for men at high risk—including African Americans and men who have a first-degree relative diagnosed at age 65 or younger, or age 40 with two or more first-degree relatives diagnosed at age 65 or younger.11

Colorectal cancer. Colonoscopies allow doctors to see and remove polyps that can lead to cancer. The American Cancer Society recommends that regular colorectal cancer screenings begin at age 45, unless you are at a higher risk due to a personal history of colorectal cancer and polyps, a family history, IBD, and/or previous radiation.12


BioMatrix Specialty Pharmacy is proud to make a difference in the communities we serve, one patient at a time.

Our clinicians and support staff offer a tailored approach to every therapeutic category, improving quality of life for patients and producing positive outcomes along the healthcare continuum. Learn more about the exceptional service and support we provide for patients requiring infused or injectable medications.


DISCLAIMER: THIS IS NOT MEDICAL OR LEGAL ADVICE. All information, content, and material is for informational purposes only and is not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider or as legal advice. Please consult a physician or other health care professional for your specific health care and/or medical needs or concerns and never disregard professional medical advice or delay in seeking it because of something you have read here or on our website.


Stay informed on the latest trends in healthcare and specialty pharmacy.

Sign up for our monthly e-newsletter, BioMatrix Abstract.

By giving us your contact information and signing up to receive this content, you'll also be receiving marketing materials by email. You can unsubscribe at any time. We value your privacy. Our mailing list is private and will never be sold or shared with a third party. Review our Privacy Policy here.


References

  1. National Kidney Foundation. How Your Kidneys Work. https://www.kidney.org/atoz/content/howkidneysw

  2. National Kidney Foundation. Chronic Kidney Disease (CKD) Symptoms and Causes. https://www.kidney.org/atoz/content/about-chronic-kidney-disease

  3. National Kidney Foundation. Fast Facts. https://www.kidney.org/news/newsroom/fsindex#:~:text=1%20in%203%20adults%20in,)%2C%203%20men's%20kidneys%20fail.

  4. Borumandnia, N., Majd, H. A., Doosti, H., & Olazadeh, K. (2022). The trend analysis of neurological disorders as major causes of death and disability according to human development, 1990-2019. Environmental science and pollution research international, 29(10), 14348–14354. https://doi.org/10.1007/s11356-021-16604-5

  5. Mayer, M. (2022). Autoimmunity on the Rise. Global Autoimmune Institute. https://www.autoimmuneinstitute.org/articles/about-autoimmune/autoimmunity-on-the-rise/#

  6. Haghighi, A. S. (2022). How Common is Rheumatoid Arthritis? Medical News Today. https://www.medicalnewstoday.com/articles/rheumatoid-arthritis-prevalence#how-common-is-ra

  7. Centers for Disease Control and Prevention (CDC). Men and Heart Disease. https://www.cdc.gov/heartdisease/men.htm

  8. Mayo Clinic. Heart Disease. https://www.mayoclinic.org/diseases-conditions/heart-disease/symptoms-causes/syc-20353118

  9. Banner health. Skin Cancer: Men Vs. Women. https://www.bannerhealth.com/healthcareblog/teach-me/skin-cancer-men-vs-women#:~:text=Compared%20to%20women%2C%20men%20are,more%20likely%20to%20develop%20it.

  10. American Cancer Society. Can Prostate Cancer Be Found Early? https://www.cancer.org/cancer/prostate-cancer/detection-diagnosis-staging/detection.html

  11. American Cancer Society. American Cancer Society Recommendations for Prostate Cancer Early Detection. https://www.cancer.org/cancer/prostate-cancer/detection-diagnosis-staging/acs-recommendations.html#:~:text=The%20discussion%20about%20screening%20should,risk%20of%20developing%20prostate%20cancer

  12. American Cancer Society. American Cancer Society Guideline for Colorectal Cancer Screening. https://www.cancer.org/cancer/colon-rectal-cancer/detection-diagnosis-staging/acs-recommendations.html


Advocating for the Women in My Life

By Anonymous


As with many young couples, my wife and I were thrilled and terrified when we first learned we were going to become parents. Although we had been married for three wonderful years, we were not sure we were ready for the responsibility that comes with bringing a new life into this world. But as with most parents, even after 16 hours of induced labor, we both could not imagine our lives without our son.

As all first-time parents believe, our son was perfect, but over the next few days, we noticed his coloring was somewhat pale. After multiple calls to the pediatrician and a visit to the hospital, our son was diagnosed with jaundice and spent several days in the hospital. Worried, but still in awe of this new life, we brought him home to begin our new life as a family.

At four months, we noticed a small bruise on his knee, but the pediatrician told us it was nothing to worry about and so we didn’t. After a few days, the bruise was not dissipating, and we noticed it looked swollen so we took him to the local children’s hospital. What followed was a terrifying sequence of tests, mistakes and follow-up visits until we were finally told our son had severe hemophilia A. Neither of us knew anything about hemophilia and we spent his early years learning and searching for answers.

When our second son was born, we knew exactly what we needed to do. He was tested at birth, and he too was diagnosed with severe hemophilia A. This time we felt slightly more confident about how to handle his diagnosis. Having two sons with hemophilia allowed us to see firsthand the similarities and differences this condition presents in every patient.

During this period my wife and I began to discuss her bleeding issues and how debilitating her menstrual cycle had been throughout her life. We launched a dialogue about her concerns with our son’s hematologist and were told her difficulties were not related to a bleeding disorder. Over the next few years, we settled into parenthood and life with a bleeding disorder and all the ups and downs that come with raising a family. As a couple, we had decided not to have more children, primarily due to the probability of having another child with a bleeding disorder.

As our children grew so did the problems with my wife’s menstrual cycle. After multiple attempts to have her tested at the HTC to no avail, my wife discussed her issues with her gynecologist. After learning about her family history of bleeding disorders, her gynecologist submitted an order for a blood test to check her factor levels. The HTC was forced to review the results of the blood tests and it was determined she had 25% factor VIII which classified her as having mild hemophilia. The HTC told her she was considered, in their opinion, a symptomatic carrier. Although this was not the ideal diagnosis, we were content her issues were finally being acknowledged even though no medication was recommended or prescribed.

Our plan to not have more children did not work out as four years after our second son was born, we were given a delightful surprise in the form of a beautiful daughter. Naturally, we were concerned about our daughter’s potential for having bleeding issues like her brothers and mother. When we brought this up to our hematologist, we were told in no uncertain terms that girls are only “carriers” and there was no need to be concerned. We asked if she could be tested regardless to learn her factor levels but we were told the test was not medically necessary and as such, not covered by our insurance. We accepted the information, albeit with some apprehension, and continued our familial journey.

After the birth of our daughter, my wife continued to have bleeding difficulties that only increased in severity. Ultimately, she was diagnosed with uterine polyps due to years of excessive bleeding that was never treated appropriately. Her gynecologist stated the only way to effectively treat her condition was with a complete hysterectomy.

It was a difficult time for my wife, not only because of the surgery but also due to the lifetime of hormone therapy that would become necessary. In addition to the frustration of this new circumstance came the knowledge that if she had been treated as a hemophiliac, like our sons, some of this would likely have been avoided. 

My wife and I immediately turned our attention firmly to the health of our daughter. We both agreed we would do anything necessary to avoid our daughter having to live through the same bleeding issues and consequences that her mother endured. My wife joined a women’s bleeding disorders support group to learn more about bleeding issues in general and to connect with other women in the community. We attended educational programs and began to prepare ourselves for the struggle we knew was coming. 

When our daughter became a woman, we knew exactly what to do. The month after her first menstrual cycle she was seen by her gynecologist, and we explained how debilitating the cycle had been along with our family history of bleeding disorders. The gynecologist immediately ordered blood tests to determine her factor levels. An HTC appointment was scheduled to review the results of the tests. At the appointment, we were told that her factor levels classified her as a symptomatic carrier. When we asked about the severity of her menstrual cycle, we were told it was relatively normal for some women to have excessive bleeding. After discussing my wife’s history with the doctor and her eventual surgery, the hematologist ordered Stimate® and Amicar® to be used as necessary.

The HTC told us we would receive a diagnosis card in the mail to verify her condition. When the card was received, it stated our daughter was diagnosed with von Willebrand disease. I called the HTC to ask about her hemophilia A status and was told the diagnosis on her card was correct. I questioned which blood test showed a deviation in her von Willebrand factor and none could be found.

I politely requested a corrected diagnosis card be sent and the clinic agreed. The following week we received a new card listing the diagnosis as mild hemophilia A and von Willebrand disease. Our daughter has done well with her treatment over the years.

Several months ago, our daughter was recommended for a minor surgical procedure to remove a cyst. Naturally, the surgeon requested a medical clearance to be completed by her hematologist before surgery. During the HTC visit, her first in a few years, the hematologist informed us that the surgery should not be an issue as she was a von Willebrand’s patient and no treatment should be necessary. Even though our daughter is a teenager she asked me to be with her during the exam and I felt the need to correct the hematologist about her diagnosis. I asked if she could show me the test results that supported the diagnosis, and she answered that no tests were available in her chart.

The hematologist turned to my daughter and made the following statement, “There is no reason to worry. Women do not have bleeding issues.” At this point, my daughter looked at me somewhat confused, as if to ask, “Are you sure I have a bleeding disorder?” I must admit I felt a wave of frustration towards this “specialist” and concern, not only for my daughter, but for all the other young women who are potentially meeting with hematologists around the country and receive this same statement – this brush-off and lack of treatment, making them feel as if everything being experienced is either made up or unimportant, and neither is true.

I spent the next few minutes discussing my experience with women living with bleeding issues and the number of women that I know personally who require prophylactic intervention due to their condition. The doctor quickly backtracked and stated she meant that women who are bleeders are rare, to which I stated, “Hemophilia is rare.” The doctor decided to confirm my daughter’s diagnosis by ordering a panel of blood tests to check her levels.

A few weeks later, my daughter and I were at the HTC to review the results of her blood tests. This time we were seen by the clinic’s medical director, who reviewed the tests and explained the results did show that our daughter was a “carrier” of hemophilia A and due to her factor VIII level of 36%, she may need some treatment before surgery. I mentioned that if her diagnosis was simply as a carrier, our insurance might give us some difficulty reimbursing for factor. The doctor agreed and stated he would make a note in her chart that a 36% factor level constituted a mild hemophilia A diagnosis. To finally hear those words come out of an HTC hematologist about my daughter was an affirmation of what we believed all along.

I felt elated that we were finally able to confirm what my wife and I had known since the first set of blood tests were performed several years prior. At the same time, my heart sank thinking about all those young girls and women who have battled bleeding issues their entire adult lives and do not have access to someone who can and will advocate for and with them. To classify a woman as a “carrier” is to put her in a box and say she is fine. Technically anyone who has hemophilia, male or female, is a carrier. Think about it - men with hemophilia carry that chromosome to every daughter he fathers. Ergo, men, too, are carriers. We need to continue to work and advocate until everyone, regardless of their gender, receives the same level and quality of care possible.


Stay informed on the latest trends in healthcare and specialty pharmacy.

Sign up for our monthly e-newsletter, BioMatrix Abstract.

By giving us your contact information and signing up to receive this content, you'll also be receiving marketing materials by email. You can unsubscribe at any time. We value your privacy. Our mailing list is private and will never be sold or shared with a third party. Review our Privacy Policy here.


Our First Year of Living with Hemophilia: a Reflection

By Jeremy Sobotka with Ragina Auch


Ragina and I are the parents of two adorable children – Jade, age 14 and Tristan, 9. We were introduced to the world of bleeding disorders when our son was diagnosed with severe hemophilia B. We’ve learned a lot in the past few years and would like to share the experiences of our first year.


After Tristan was born, his heel was pricked for routine newborn lab work. Throughout the day, the tiny puncture bled through the bandage and booties and onto the blanket. His nurse did a complete bandage, bed and clothing change. The next day, another nurse came in and changed the bandage, put clean clothes on, and brought in fresh blankets. On the third day another nurse arrived to change everything again, and this time I asked, “Why is he still bleeding?” I mentioned that the other nurses had changed everything each day prior because of the bleeding. Apparently, the nurses had not communicated that with each other and the doctor was unaware. When the doctor was notified, a blood draw was ordered to test his platelet count and check for other bleeding disorders. Later that afternoon he came in and gave us the shocking news that Tristan had hemophilia.

Our initial reaction to learning our son has severe hemophilia B was one of fear, grief, confusion and hopelessness. Though Ragina had heard of hemophilia, she didn’t know much about it. Never having heard of it myself, I didn’t even know how spell it! I hoped Tristan would just be given some kind of medicine, and everything would be fine. When I understood it was a lifelong medical condition, I instantly felt sick to my stomach, angry, scared and helpless.

It wasn’t until the 3rd or 4th visit to the hemophilia treatment center when the doctor suggested inserting a port so Tristan could be placed on a weekly prophylactic schedule that I began to realize the lifelong impact. There really isn’t anything that can or would prepare a parent for that kind of news. Everything sounded even worse when our pediatrician said he had never had a patient with hemophilia in his 30+ years of being a doctor.

As Tristan started learning how to get around, bruises began appearing all over. As the bruising increased with his activity level, we became more interested in having a port placed so he could start prophy treatments. However, we had to wait until after Tristan’s first birthday to proceed. He was already walking, and we knew things could get worse. 

At first Ragina and I had split opinions on the decision to have a port inserted. After all, who wants to have their child go through any surgery, especially at a year old? 

After weeks of debating, we decided it would be best for him to have a port. After going through all the difficult blood draws and injections, we have been happy with our decision. For us, it’s been a night and day difference - now that we can give him his treatments and have labs drawn without a single tear! Learning to infuse him via the port was nerve racking at first, but it became our weekly evening family ritual that we did together. Jade’s job was to keep Tristan entertained as I held him while Ragina did the infusion.

He didn’t experience many bleeds before the port was placed, so we have not learned how to access a vein. At nine-years-old, Tristan’s port is still fully functioning, but we are now exploring how best to learn to infuse our son through venous access.

Since those early days, we have accepted that Tristan will have hemophilia forever, or at least until a cure is found. We have realized the best thing we can do is learn as much as possible about his bleeding disorder so we can be better prepared to teach him as he grows up. We’ve been doing our best to treat Tristan as normally as possible. At the same time, overprotectiveness kicks in and sometimes I just want to put him in a bubble. On occasion, we have to get on our daughter because she tends to play rough with him, but he is usually the one instigating the horseplay! As he’s gotten older, he’s proven to be a typical boy who loves to climb and get into things… go figure!

With my son’s first year of life, I have learned that when it comes to bad news about my family, I tend to blow it way out of proportion. I am supposed to be the rock for them to lean on and I admit I am the least qualified for the job. I envy Ragina for being able to keep her cool and be strong enough to handle everything better than I do.

Presently, even though we are not together as a couple, we continue to work together for the benefit of Tristan’s health. We have worked well together in both routine and emergent care. Jade, even years later, still enjoys roughhousing with her younger brother! 

Tristan is doing very well these days and enjoys video games, playing with his friends and family, driving an ATV, and has just signed up for 4-H. He hasn’t had many emergencies, a few stitches, but the biggest issue he continues to experience are bleeds in his ankles. We are in the process of having his dosage adjusted and getting orthopedic inserts for his shoes to hopefully help with that. You would never know by looking at him that he has hemophilia, he is just a normal 9-year-old boy living life to the fullest. 

Hemophilia has been an experience for all of us. It has taught us a whole new level of patience. Tristan didn’t understand in that first year that anything was wrong with him. Even now, his hemophilia has been so well controlled that in his eyes, the problem he has is with the port and treatment rather than bleeding episodes. I don’t want him to know any different! Kids with hemophilia are the same as any child and shouldn’t be treated differently – they still play and fight with siblings. Just remember to be a bit more cautious and alert and know they will have a few extra bruises now and again no matter how careful they are. Take each day one at a time and have faith everything will work out fine!


Stay informed on the latest trends in healthcare and specialty pharmacy.

Sign up for our monthly e-newsletter, BioMatrix Abstract.

By giving us your contact information and signing up to receive this content, you'll also be receiving marketing materials by email. You can unsubscribe at any time. We value your privacy. Our mailing list is private and will never be sold or shared with a third party. Review our Privacy Policy here.


In Search of Support

By Fel Echande


My family is a mix of Costa Rican and Mexican descent, and we have lived in the USA for 24 years now. I am a commercial driver, and my wife, Laura, is a photographer. We have two sons, Fiach, 22 years-old, and Yanni, who is 17.


Our first-born son was diagnosed with severe hemophilia B at 10–months old. After consistently showing up to the pediatrician’s office with unexplained bruising, our physician suspected abuse. However, after running a battery of blood tests, it became evident that Fiach has hemophilia.

With no family history of a bleeding disorder, we knew very little about hemophilia. We had a lot to learn. We knew the diagnosis was going to be a struggle, but thanks in part to amazing support from the bleeding disorder community, our family is thriving.

Twenty-plus years ago, the internet was in its infancy. In those early days, the lack of information was challenging us. There was very little information available in Spanish.

My wife came across a book authored by Laurie Kelley, which had been translated to Spanish (no longer available in Spanish). The book proved to be a huge help for us as we struggled to find more information.

Outside of the clinical support provided by our medical team, we began to realize the importance of connecting with others in the bleeding disorders community. Becoming involved with local and national chapters was instrumental in broadening our education, comfort, and ability to deal with hemophilia.

Laura and I began meeting so many wonderful people in the community. Each friendship brought a fresh perspective and helped us see that our son could live a largely normal life. We learned so much from the individuals and families having already walked in our shoes.

Making friends with other children with hemophilia helped our son understand that he is not alone in the world. The friendships taught him to embrace life with a bleeding disorder. When things were stressful for us as parents or for Fiach as an affected child, we knew we could lean into community-based support provided by our local chapter and organizations like The Coalition for Hemophilia B.

Through our involvement we learned to be strong advocates for ourselves, for our son, and for others in the bleeding disorders community.  As the years went by, we became more knowledgeable and confident and were compelled to get involved and give back to the community that had helped us so much.

We are now very involved in volunteering. I am currently on the board of directors for the Hemophilia Association of San Diego County. My wife and I have been part of National Hemophilia Foundation’s Guias Culturales (Cultural Guides helping NHF with workshops for the Hispanic families). My wife was involved with the Hemophilia Chapter of Northern California’s The Female Factor Retreat. We are both very involved nationally with The Coalition for Hemophilia B and we also lead community support groups to help our local families.

We encourage all bleeding disorder families to get involved, get educated, and take advantage of the support provided by the organizations serving this community locally and nationally. Attend events, connect with families, and learn through our shared experiences. For those who are dealing with a new diagnosis know that it does get better. Our community is a family—don’t ever be hesitant to reach out.


Spanish Language Resources


The Coalition For Hemophilia B
Newsletters in English and Spanish

www.hemob.org/newsletter

www.hemob.org


National Hemophilia Foundation
Guias Culturales (Cultural Guides)

https://www.hemophilia.org/educational-programs/outreach/guias-culturales

HemAware en español, https://hemaware.org/es


Hemophilia Federation of America
Sangre Latina

https://www.hemophiliafed.org/join-sangre-latina/


Stay informed on the latest trends in healthcare and specialty pharmacy.

Sign up for our monthly e-newsletter, BioMatrix Abstract.

By giving us your contact information and signing up to receive this content, you'll also be receiving marketing materials by email. You can unsubscribe at any time. We value your privacy. Our mailing list is private and will never be sold or shared with a third party. Review our Privacy Policy here.


Guillain-Barré syndrome (GBS): Signs, Symptoms, and Treatment Options


With an estimated 3,000 to 6,000 people in the U.S. developing Guillain-Barré syndrome (GBS) every year1, GBS is a rare neurological disorder in which the body's immune system attacks its own nerves causing muscle weakness and sometimes complete paralysis. It’s most common between ages 30-50, though onset can happen at any age.2

Though the cause of GBS is not fully understood, two-thirds of patients report a viral or bacterial infection in the weeks prior to GBS symptoms—typically gastrointestinal or respiratory. Evidence suggests that this infection triggers the immune response which damages the myelin sheath that protects the nerves, leading to numbness and weakness. Most people recover fully from GBS and are able to walk within 6 months to two years of when symptoms began. However, some have lasting effects, and for some, the disease can be fatal.3


Signs and Symptoms

Early signs of GBS often include a rapid onset of tingling, weakness, and numbness that start in the feet and legs and spread to the upper body. Some people notice these symptoms first in their arms or face. While initial weakness may be mild, symptoms can progress rapidly over just a few days. Additional signs and symptoms may include:

  • Difficulty raising a foot or walking without assistance

  • Paralysis or the loss of ability to move one’s legs, arms, breathing muscles, and face

  • Paralysis that travels up the limbs from fingers and toes towards the torso

  • Loss of reflexes such as the knee jerk

  • Pain in the muscles

  • Blurred vision

  • Difficulty swallowing or chewing

  • Difficulty speaking

  • Shortness of breath or difficulty breathing

  • Low or high blood pressure

  • Difficulty with bladder control or bowel function

  • Rapid heart rate

It’s important to note that not all patients with GBS experience paralysis. Some with mild cases may just experience tingling and weakness throughout their body.


Treatment Options

For some with mild symptoms, no treatment is necessary. For most new cases of GBS, however, patients need to be hospitalized. To monitor breathing and other body functions, patients are typically admitted to the ICU (Intensive Care) until the condition is stabilized. Although there is no cure for GBS, immune-suppressing treatments can prevent breathing problems and relieve symptoms by reducing the inflammation caused by the immune system’s response to the disease. Both plasmapheresis (plasma exchange) and intravenous immunoglobulin (IVIG) are used to treat GBS, and IVIG suppresses the inflammatory response.

Derived from thousands of healthy blood plasma donations, immunoglobulin therapy can help suppress an overactive immune system by preventing it from attacking healthy cells. Immunoglobulin given intravenously, or through a vein, is called intravenous immunoglobulin (IVIG).


Helpful Resources

The GBS/CIDP Foundation International provides support and resources for GBS patients and their families. Some of these resources include:

  • Local community groups and chapter meetings

  • Community forums

  • GPS educational webinars and conferences

  • Rehabilitation guide for caregivers


How BioMatrix Can Help

Though a GBS diagnosis can feel overwhelming for you or a loved one, it’s important to know that you are not alone. Organizations like GBS/CIDP Foundation International mentioned above can provide a wealth of information and support as well as connect you to others in the community who have experienced the same diagnosis. In addition, your specialty pharmacy can offer individualized support to help manage treatment.

BioMatrix helps manage the individual needs of patients requiring IVIG therapy. Knowledgeable pharmacists and care coordination staff guide each patient through the potential medication side effects and, working with the prescribing physician, help manage treatment to reduce the prevalence and severity of relapses.

The BioMatrix clinical team includes compassionate nurses who have extensive training and experience with rare diseases, infusion therapies, and complex medical conditions. Our nurses work together with patients, caregivers, pharmacists, and prescribers to coordinate the optimal site of care, conduct nursing interventions, and provide patient education.


Learn more about our individualized specialty pharmacy services for patients with GPS and other neurological conditions.


Insurance Appeal Letter Sample & Template

Have you been denied insurance coverage for much needed treatment? Use this appeal letter template as a guide to help you or a loved one appeal insurance claim denials.


DISCLAIMER: THIS IS NOT MEDICAL OR LEGAL ADVICE. All information, content, and material is for informational purposes only and is not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider or as legal advice. Please consult a physician or other health care professional for your specific health care and/or medical needs or concerns and never disregard professional medical advice or delay in seeking it because of something you have read here or on our website.


Stay informed on the latest trends in healthcare and specialty pharmacy.

Sign up for our monthly e-newsletter, BioMatrix Abstract.

By giving us your contact information and signing up to receive this content, you'll also be receiving marketing materials by email. You can unsubscribe at any time. We value your privacy. Our mailing list is private and will never be sold or shared with a third party. Review our Privacy Policy here.

References

  1. (2023). Guillain-Barré Syndrome and Vaccines. CDC. https://www.cdc.gov/vaccinesafety/concerns/guillain-barre-syndrome.html

  2. Guillain-Barré Syndrome. Mount Sinai Today Blog. https://www.mountsinai.org/health-library/diseases-conditions/guillain-barr-syndrome

  3. (2022). Guillain-Barré Syndrome. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/guillain-barre-syndrome/symptoms-causes/syc-20362793

BioMatrix Specialty Pharmacy Welcomes Kathee Kramm to Executive Team


Kramm Appointed as President and Chief Operating Officer

Media Contact: Tara Marchese
Corporate Director of Marketing
Tel: 954-908-7636
Email: tara.marchese@biomatrixsprx.com

May 16, 2023 – Plantation, FL - BioMatrix Specialty Pharmacy announced today Kathee Kramm has joined the executive leadership team as President and Chief Operating Officer. Working in collaboration with the CEO and CFO, Kathee will oversee sales, operations, nursing, and revenue cycle management. She will play an integral role in BioMatrix’s strategic priorities as a leader in the specialty infusion pharmacy industry.

Ms. Kramm is an accomplished, entrepreneurial healthcare executive extensively experienced in specialty pharmacy and home infusion.  She has successfully designed and implemented growth strategies for several industry-leading infusion, specialty, and mail order pharmacies. Kathee has also successfully transitioned businesses through multiple private equity recapitalizations and participated in sale negotiations and integration efforts.  

Most recently, Kathee served as President and Co-Founder of AxelaCare Health Solutions (now Optum Infusion), where her key areas of focus included operations, building national sales teams, nursing networks, and payer alliances to improve care and therapy access for patients with rare and chronic health conditions. Prior to AxelaCare, Kathee was a co-founder of Home Patient Care which eventually was sold to Amerisource Bergen and rebranded as US BioServices. 

“We are excited to partner with Kathee and welcome her to our executive leadership team,” CEO Nick Karalis affirms. “Kathee ’s background, experience, and leadership will further enhance BioMatrix’s investment and focus on specialty infusion, bleeding disorders, 340b, and HUB/ LDD services. Her skill set combined with her enthusiasm and entrepreneurial spirit makes her a perfect addition to the team.”

Kathee Kramm shares, “I am impressed with and motivated by the staff and the resources BioMatrix possesses. The wealth of industry experience, resources, and passion BioMatrix has in prioritizing patient care above all else is unique in the specialty infusion pharmacy space. I am elated to be a part of the BioMatrix family and look forward to playing a role in the continued growth of the organization.” 

For more information on BioMatrix Specialty Pharmacy, please visit www.biomatrixsprx.com.


About BioMatrix Specialty Pharmacy
BioMatrix Specialty Pharmacy, an Inc. 5000 company, offers comprehensive, nationwide specialty infusion pharmacy services and digital health technology solutions for patients with chronic, difficult to treat conditions. Our commitment to every patient is to provide individualized pharmacy services, timely access to care, and focused education and support. We offer a tailored approach for a wide range of therapeutic categories, improving health and empowering patients to experience a higher quality of life.


Myasthenia Gravis (MG): Signs, Symptoms, Positive Self-Management, and Treatment Options


Myasthenia gravis (MG) is a rare, autoimmune neuromuscular disease that’s characterized by weakness in the voluntary muscles (muscles you can control) such as the eyes, face, jaw, neck, arms, and legs. With MG, the immune system attacks the communication between the nerve signals and the muscles, causing weakness and loss of control of these muscles.

Though MG can occur at any age, the onset of symptoms most commonly happens in women under 40 and men over 60.1


Signs and Symptoms

Ocular weakness is typically one of the first signs of MG. This is when muscles that control eye and eyelid movement cause a partial paralysis of eye movements, double vision, and droopy eyelids. Roughly half of those who first experience these symptoms will go on to develop muscle weakness and/or fatigue in the rest of their body within two years—typically in their neck and arms first, then their legs.2 Lifting one’s arms over their head, standing up from a seated position, walking long distances, and climbing stairs may become more and more difficult. MG symptoms can appear suddenly with rapid fatigue and loss of muscle control.


Positive Self Management

The Myasthenia Gravis Foundation provides a wealth of resources for MG patients and their families including disease education, research, community events, and wellness strategies. In addition to a patient’s medical/treatment protocol, wellness strategies and positive self management can improve day-to-day quality of life for those living with MG. According to the Myasthenia Gravis Foundation, some of those strategies include:

  • Sharing facts about MG with family, friends, and coworkers as you feel comfortable

  • Learning ways to cope

  • Conserving energy

  • Staying cool

  • Accepting help

  • Potentially recovering some strength through low impact movement and exercise

  • Proper nutrition and diet modification to help with chewing and swallowing

  • Learning your rights in the workplace

You can learn more and dive deeper into these wellness strategies here.


Treatment Options

Although there is no cure for MG, treatment can help relieve and lessen symptoms. The type of treatment depends on age, disease severity, and how fast it’s progressing. Medications like cholinesterase inhibitors can improve muscle contraction and muscle strength in some people. Corticosteroids, like prednisone, can lessen the immune system attacks. Immunosuppressants can help alter the immune system. All of these medications, however, can cause serious side effects with prolonged use.3

Infusion treatments such as IVIG and other infused medications are typically used to treat worsening MG symptoms. Because medication is infused directly into the bloodstream, a healthcare professional should be present to administer the infusion and monitor the patient for side effects.


How BioMatrix Can Help

BioMatrix helps manage the individual needs of patients requiring infused medications by providing options for administration site of care, education, and support to help improve quality of life. Knowledgeable pharmacists and care coordination staff guide each patient through the potential medication side effects and, working with the prescribing physician, help manage treatment to reduce the prevalence and severity of relapses.

The BioMatrix clinical team includes compassionate nurses who have extensive training and experience with rare diseases, infusion therapies, and complex medical conditions. Our nurses work together with patients, caregivers, pharmacists, and prescribers to coordinate the optimal site of care (including home infusion), conduct nursing interventions, and provide patient education.


Learn more about our individualized specialty pharmacy services for patients with MG and other neurological disorders.


DISCLAIMER: THIS IS NOT MEDICAL ADVICE. All information, content, and material is for informational purposes only and is not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider. Please consult a physician or other health care professional for your specific health care and/or medical needs or concerns and never disregard professional medical advice or delay in seeking it because of something you have read here or on our website.


Stay informed on the latest trends in healthcare and specialty pharmacy.

Sign up for our monthly e-newsletter, BioMatrix Abstract.

By giving us your contact information and signing up to receive this content, you'll also be receiving marketing materials by email. You can unsubscribe at any time. We value your privacy. Our mailing list is private and will never be sold or shared with a third party. Review our Privacy Policy here.

References

  1. (2023). Myasthenia Gravis. National Institute of Neurological Disorders and Stroke. https://www.ninds.nih.gov/health-information/disorders/myasthenia-gravis

  2. Myasthenia Gravis (MG) Signs and Symptoms. Muscular Dystrophy Association. https://www.mda.org/disease/myasthenia-gravis/signs-and-symptoms

  3. (2021). Myasthenia Gravis Diagnosis & Treatment. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/myasthenia-gravis/diagnosis-treatment/drc-20352040

Multiple Sclerosis (MS): Signs, Symptoms, Positive Self-Management, and Treatment Options


Multiple sclerosis (MS) is a disease of the central nervous system (CNS)—i.e. the brain, spinal cord, and optic nerves. The CNS, which controls the entire body, is attacked by the body’s own immune system, damaging the protective layer, or myelin, that insulates the wire-like nerve fibers.

This nerve damage disrupts signals to and from the brain. MS is an immune-mediated disease, which is when the body’s immune system overreacts and attacks itself. Though similar, an immune-mediated disease is different from an autoimmune disease. Both involve the immune system attacking and damaging the body’s own healthy cells via proteins (or autoantigens—antigens produced by one’s own body). However with an autoimmune disease, the proteins/autoantigens which attack the cells have been identified. With an immune-mediated disease, these proteins/autoantigens have not been identified.1


Signs and Symptoms

Though everyone’s experience with MS is different, there are some common signs and symptoms to look out for. These include:3

  • Numbness or weakness in one or more limbs, typically occurring on one side of the body at a time

  • Tingling

  • Electric-shock sensations that occur with certain neck movements, especially when bending the neck forward (Lhermitte sign)

  • Lack of coordination

  • Unsteady gait (having trouble with balance) or inability to walk

  • Partial or complete loss of vision, usually in one eye at a time with pain during eye movement

  • Prolonged double vision

  • Blurry vision

  • Vertigo

  • Problems with sexual, bowel, and bladder function

  • Fatigue

  • Slurred speech

  • Cognitive problems

  • Mood disturbances


Positive Self Management

In addition to a patient’s medical/treatment protocol, positive self management can improve day-to-day quality of life for those living with MS. Patients who self-manage their condition have the skillset to accept and communicate with others their need to move at their own pace. Research has shown that those who have developed self-management skills have more confidence to better communicate their needs to others, therefore receiving improved support.4 Found to be an empowering strategy to improve health for many people living with chronic conditions, self management is a philosophy that acknowledges living with a condition like MS is an ongoing experience.

The National Multiple Sclerosis Society and Multiple Sclerosis Foundation both give resources for developing positive self management skills. 

The National Multiple Sclerosis Society has a section on their website dedicated to “Living Well with MS”. They provide guidance and resources for diet, exercise, and healthy behaviors; emotional well-being (i.e. managing stress and coping skills); spiritual well-being (i.e. building on values and beliefs that provide purpose); and cognitive health (i.e. keeping your mind engaged and challenged). Learn more about these resources here

The Multiple Sclerosis Foundation is helping MS patients get connected to support groups and grants. Some of their grants and programs include help with rent or utilities, homecare assistance, and transportation. They also host multiple events for the MS community to join together and learn more about managing their condition. To learn more about these resources and events, click here.


Treatment Options

For some with mild symptoms, no treatment is necessary. For others, treatment to help ease MS symptoms may include corticosteroids or plasma exchange. Although there is no cure for MS, treatment can also help slow disease progression by reducing the amount of damage and scarring to the myelin—the layer surrounding the nerves. This reduction in damage can help MS patients have fewer and less severe relapses. Treatment to slow progression may include injectable, oral, and infusion medications. 

Infusion treatments may help slow the progression of MS and lessen flare-ups for those with aggressive or advanced MS. Because medication is infused directly into the bloodstream, a healthcare professional should be present to administer the infusion and monitor the patient for side effects.


How BioMatrix Can Help

BioMatrix helps manage the individual needs of patients requiring infused medications by providing options for administration site of care, education, and support to help improve quality of life. Knowledgeable pharmacists and care coordination staff guide each patient through the potential medication side effects and, working with the prescribing physician, help manage treatment to reduce the prevalence and severity of relapses.

The BioMatrix clinical team includes compassionate nurses who have extensive training and experience with rare diseases, infusion therapies, and complex medical conditions. Our nurses work together with patients, caregivers, pharmacists, and prescribers to coordinate the optimal site of care (including home infusion), conduct nursing interventions, and provide patient education.


Learn more about how our individualized specialty pharmacy services for MS patients.


Financial Resource Guide

Living with a chronic condition can create additional healthcare costs while also impeding one’s ability to work. Our financial resource guide can help. 


DISCLAIMER: THIS IS NOT MEDICAL OR LEGAL ADVICE. All information, content, and material is for informational purposes only and is not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider or as legal advice. Please consult a physician or other health care professional for your specific health care and/or medical needs or concerns and never disregard professional medical advice or delay in seeking it because of something you have read here or on our website.


Stay informed on the latest trends in healthcare and specialty pharmacy.

Sign up for our monthly e-newsletter, BioMatrix Abstract.

By giving us your contact information and signing up to receive this content, you'll also be receiving marketing materials by email. You can unsubscribe at any time. We value your privacy. Our mailing list is private and will never be sold or shared with a third party. Review our Privacy Policy here.

References

  1. What is an immune-mediated disease? The National Multiple Sclerosis Society. https://www.nationalmssociety.org/What-is-MS/Definition-of-MS/Immune-mediated-disease

  2. About Multiple Sclerosis (MS). Penn Medicine. https://www.pennmedicine.org/for-patients-and-visitors/patient-information/conditions-treated-a-to-z/multiple-sclerosis-ms

  3. (2022). Multiple Sclerosis. Mayo Foundation for Medical Education and Research (MFMER). https://www.mayoclinic.org/diseases-conditions/multiple-sclerosis/symptoms-causes/syc-20350269

  4. (2010). Wazenkewitz, J., McMullen, K., Ehde, D. Self-Management: Keys to Taking Charge of Your MS. Multiple Sclerosis Foundation.

Time to Rethink Women and Bleeding Disorders: Stop the Unnecessary Suffering!

By Linda “Lew” E. Wyman-Collins, BSN, RNC-NIC


As a woman with hemophilia A, a platelet disorder and Ehler’s Danlos Syndrome (EDS), the bleeds I experience are more in line with moderate to severe hemophilia. At age 65, I suffer with various medical complications and side effects from receiving a later-in-life diagnosis. I did not obtain a diagnosis or proper/adequate treatment for most of my life. The pursuit of equal or compatible treatment that my blood brothers receive has been a struggle.


Throughout my life, dental work and cleanings caused extensive bleeding. Impacted wisdom teeth caused me needless mouth pain for many years, but because of how easily my mouth bled, no one wanted to extract them. Finally at 52, I found an oral surgeon who agreed to remove them with treatment prior to procedure. I experienced senseless tooth and mouth pain for so many years. Now I treat with DDAVP nasal spray prior to all dental appointments, and the bleeding is minimal.

When I was 11 years old, I began having gastrointestinal bleeding. Physicians believed I had colitis; the treatment was dietary changes and medications. The mucosal lining of my lower intestine is permanently damaged from years of uncontrolled bleeding. Now with a proper diagnosis, I am able to effectively treat with clotting factor, desmopressin (DDAVP®) and tranexamic acid (Lysteda®).

All my life, I have bruised very easily and when my menstrual cycles started, I bled heavily with large clots for more than seven days every month. When I voiced my concern to my doctors, I was told my cycle was “normal” because my mother and grandmother also had heavy cycles and that being a fair-skinned redhead added to the bruising. In retrospect, my mother and grandmother both had undiagnosed bleeding disorders. Due to the prolonged bleeding each month, I had chronic anemia, which greatly affected my quality of life.

In 7th grade I injured my knee during gym class. When I look back at that injury, it was clearly a muscle and joint bleed. As I grew older, my left knee deemed itself my target joint. It is chronically swollen with decreased range of motion; x-rays reveal the knee joint is now bone-on-bone. Steroids and gel injections only offer temporary relief, and I am now considering a knee replacement. Had my joint bleeds been treated properly when I was younger, the extensive joint damage could have been avoided or at least lessened. I now wear rib, back, knee and thumb braces due to impaired joints.

Current studies are revealing a correlation between Factor VIII deficiency and bone health, and I have been diagnosed with osteopenia. Women with a bleeding disorder are developing osteopenia and osteoporosis at an earlier age.

In 1983, when my oldest son was diagnosed with severe hemophilia A at 17 months, scientists had not yet discovered the gene where the mutation occurred. When DNA testing became available, I was tested, and the results showed I had the same gene mutation as all 3 of my children, yet despite my bleeding history, I was labeled as just a “symptomatic” carrier.

At 35, I had an inguinal hernia repair scheduled but at that time, wasn’t being seen by a hematologist. After reading in my medical record that I was a carrier, the anesthesiologist refused to clear me for surgery until I was seen by a hematologist. I went to a hemophilia treatment center and was tested and was diagnosed with a platelet disorder.

Shortly after, I was identified as having EDS and was then prescribed DDAVP via IV for any surgery or invasive procedure. Tranexamic acid and aminocaproic acid (Amicar®) helped with menstrual cycles and mucosal bleeds. In my late 40’s, I was finally properly diagnosed with a bleeding disorder and received appropriate treatment for chronic anemia; yet I was not given access to clotting factor for another 17 years.

Unfortunately, the majority of the medical community is often still under the notion that only males can have a bleeding disorder. The assumption is women are only carriers and do not need treatment. However, rather than basing care on gender, treatment should be based on documented factor levels and bleeding tendencies.

Our national organizations, non-profits, and pharmaceutical companies have done a great job at educating the community on bleeding disorders in men and women. Yet, there still remains a missing piece on prescribing proper treatment for women. Education needs to be expanded at the medical school level to instruct doctors-in-training to recognize that women can and do bleed. In the meantime, women need to advocate for themselves with a much louder voice and not allow themselves to be dismissed. In the 25 years I have been active in the bleeding disorders community on a national level, I have not seen much change in the timely diagnosis and adequate treatment for women. This needs to change.


ABOUT THE AUTHOR

Linda “Lew” E. Wyman-Collins, BSN, RNC-NIC is a mother, wife, aunt, sister, and daughter of someone with a bleeding disorder and has a bleeding disorder of her own. As a nurse, she has much experience in neonatal intensive care and was recognized as Dallas/Fort Worth Great 100 Nurses. Lew served HFA formerly on the Board of Directors, Blood Sisterhood Chair, Symposium Chair, Medical/Professional Advisory Board member, and is a founding member of HFA’s women’s group Focus on the Feminine. She has served on Texas State Bleeding and Clotting Disorders Advisory Council and is a member of Equity in Bleeding Disorders Care for Women and Others. Additionally, Lew has presented frequently at national and international conferences and has authored numerous articles on hemophilia and women with bleeding disorders in industry magazines and journals.


Stay informed on the latest trends in healthcare and specialty pharmacy.

Sign up for our monthly e-newsletter, BioMatrix Abstract.

By giving us your contact information and signing up to receive this content, you'll also be receiving marketing materials by email. You can unsubscribe at any time. We value your privacy. Our mailing list is private and will never be sold or shared with a third party. Review our Privacy Policy here.


Pemphigus—Types, Symptoms, and Treatment Options


Pemphigus is a rare group of autoimmune diseases that causes blistering of the skin and the inside of the mouth, nose, throat, eyes, and genitals. With these diseases, the immune system mistakenly attacks healthy proteins that bind skin cells to one another, causing the skin to become fragile. Blisters then form from fluid that collects between the skin’s fragile layers.1,2

Though researchers do not know what causes the immune system to fight the body’s own proteins, they believe that both genetic and environmental factors are involved. Some people may be predisposed to the condition due to their genetic makeup, and something in their environment may trigger an immune response.


Pemphigus Types and Symptoms

Signs and symptoms vary based on the type of pemphigus:1

Pemphigus vulgaris: The most common type in the US, blisters form within the mouth and other mucosal surfaces, as well as in a deep layer of the skin. They are often painful. Blisters can also form in the groin and under the arms in a subtype of the disease called pemphigus vegetans. Blisters typically start in the mouth and then appear on areas on the skin. The skin may become so fragile that it peels off by rubbing a finger on it.

Pemphigus foliaceus: Only affecting the skin, itchy or painful blisters form in upper skin layers. They typically appear first on the face, scalp, chest, or upper back, but can spread to other areas of skin on the body. The affected areas of skin may become inflamed and peel off in layers or scales.

Paraneoplastic pemphigus: Blisters or inflamed lesions typically form in the mouth and on the lips but may also develop on the skin and other mucosal surfaces. People with this type of pemphigus usually have a tumor and may have severe lung problems. If the tumor is surgically removed, the disease may improve.

IgA pemphigus: Caused by the IgA antibody, blisters or pimple-like bumps often form in groups or rings on the skin. 

Drug-induced pemphigus: Pemphigus-like blisters or sores are triggered by certain medicines like antibiotics and blood pressure medications, as well as drugs that contain a chemical group called a thiol. When one stops taking the medication or drug, these blisters and sores typically go away.


Diagnosis and Treatment

Pemphigus is typically diagnosed through a skin biopsy, blood tests, and sometimes an endoscopy to check for sores in the throat.

Treatment is dependent on the type and severity of the disease. Medications like corticosteroid cream and prednisone pills are often prescribed as the first line of treatment intended to suppress blisters. To help suppress the immune system and keep it from attacking healthy proteins, medications such as azathioprine (Imuran, Azasan), mycophenolate (Cellcept) and cyclophosphamide are typically prescribed. If these treatment methods aren’t working, treatments such as intravenous immunoglobulin (IG) therapy are typically prescribed as a second or third-line treatment option.3

Intravenous immunoglobulin (IG) therapy is usually well tolerated with few rare serious side effects. It’s been used to treat dermatological conditions for more than two decades.4


How BioMatrix Can Help

BioMatrix has extensive experience with IG-related support services. As a national provider of IG, BioMatrix has broad access to all brands and inventory. Our IG treatment plans are designed to:

  • Prevent infections

  • Boost the immune system

  • Avoid complications of therapy

  • Prevent long-term organ damage

  • Decrease hospitalizations

  • Encourage patients to participate in disease management

  • Prolong life

  • Improve general health and quality of life

Our nursing team coordinates the best site of care for scheduled infusions—whether in the patient’s home or physician’s office. Providing site-of-care options offers convenience for patients and cost savings to insurance providers.

Together, our clinicians, support staff, and digital health technology offer a comprehensive approach improving quality of life for patients and producing positive outcomes along the entire healthcare continuum.


DISCLAIMER: THIS IS NOT MEDICAL ADVICE. All information, content, and material is for informational purposes only and is not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider. Please consult a physician or other health care professional for your specific health care and/or medical needs or concerns and never disregard professional medical advice or delay in seeking it because of something you have read here or on our website.


Stay informed on the latest trends in healthcare and specialty pharmacy.

Sign up for our monthly e-newsletter, BioMatrix Abstract.

By giving us your contact information and signing up to receive this content, you'll also be receiving marketing materials by email. You can unsubscribe at any time. We value your privacy. Our mailing list is private and will never be sold or shared with a third party. Review our Privacy Policy here.

References

  1. (2021). Pemphigus. National Institutes of Health. https://www.niams.nih.gov/health-topics/pemphigus

  2. Pemphigus Vulgaris. John Hopkins Medicine. https://www.hopkinsmedicine.org/health/conditions-and-diseases/pemphigus-vulgaris

  3. (2022). Pemphigus. Mayo Foundation for Medical Education and Research (MFMER). https://www.mayoclinic.org/diseases-conditions/pemphigus/diagnosis-treatment/drc-20350409

  4. Hoffmann, J.H.O. and Enk, A.H. (2017), High-dose intravenous immunoglobulins for the treatment of dermatological autoimmune diseases. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 15: 1211-1226. https://doi.org/10.1111/ddg.13389

Living with Hemophilia: Hope for Help

By Ashley Gregory


Anthony and Nicholas were born in 1998, and although I had no family history of bleeding disorders, I now had twins with severe hemophilia A. I became informed about their condition and as they grew, stayed in close contact with our hemophilia treatment center. Also in 1998, NHF launched Project Red Flag, which advocated for women with bleeding disorders. I remember being curious because I had experienced puzzling symptoms throughout my time, but life would take a darker turn, and it would be several years before I could revisit this topic.


One day Anthony didn’t seem right; he was lethargic and not eating. I took him to our pediatrician who suspected the flu. I remember looking directly at her and saying, “Shouldn’t we infuse him since his head is hot, but he has no fever?” She said, “No, just take him home.” Instead, we took him to the emergency room where we learned he had a brain bleed. Despite heroic surgical efforts and finally infusing factor, my son died the next morning – he was only 11 months old. Thus began a slow tumble into despair that our family would not emerge from until well into the next decade.

During subsequent years, researchers were learning that women with the hemophilia gene exhibit unexplained bleeding symptoms and need treatment. Some doctors began successfully working with women to determine how to manage symptoms using factor replacement; they were learning that despite “normal” factor levels, women who experienced unexplained bleeding responded well to factor treatment with no adverse reactions. It was unexplained bleeding that pulled me back into a search for a diagnosis.

While volunteering at my local foundation, I heard women discuss similar untreated symptoms around inexplicable bleeding. It didn’t take long to realize there was a common problem. Women in our community, like me, were experiencing puzzling bleeding that was not addressed despite reporting these symptoms to their doctors. The concerns were usually explained away with comments like, sometimes these things happen, sounds like all the women in your family are like this, or this is just your normal. Were we being ignored, or did the doctors simply not believe us?

This led to a personal investigative journey to seek a diagnosis and treatment while, at the same time, pursuing a career in advocacy and education in bleeding disorders. I began attending local, regional and national programs that provided comprehensive education about my bleeding symptoms and brought me in contact with physicians who were successfully treating women’s bleeding issues using all the medications available to men with bleeding disorders.

I learned about lyonization, which is when one of the two X chromosomes in every cell of a female is inactivated. Lyonization can cause an effective X chromosome to stop working, allowing the other ineffective X chromosome to take over, producing lower factor levels. This led to an even greater understanding of my particular bleeding disorder as a woman with two X chromosomes. Thanks to Dr. Barbara Konkle and the My Life, Our Future genetic analysis project, I learned that some mutations present a high factor level but bleed like a severe! I finally learned that connective tissue disorders can also be present in persons with bleeding disorders, which can then exacerbate bleeding.

Empowered with this knowledge, I confidently entered the HTC near me and presented the information I had gathered, along with my symptoms and history. I trusted I would be heard and cared for. I could not have been more wrong. I even brought my mother along who had been by my side through all my pain and could attest to my history. The treatment center told me my factor levels were too high for my swollen ankles and knees to be caused by hemophilia, and my petechiae were birthmarks.

My unexplained bleeding history was useless in gaining a diagnosis here. I was also seen by the genetics specialist who told me I lacked enough markers to have a connective tissue disorder. I was left with the option to do nothing or to have a synovectomy on my right ankle to see what fluid it contained. Based on my past, I instinctively knew without infusing factor prior to the procedure, the healing process would be long and painful. I declined the surgery in pursuit of a better option. 

It was time to try a new approach. I crossed state lines and met with an expert clinician I had met at a national symposium. After a thorough medical evaluation, complete history review of symptoms, physical evaluation and lab workup, I was diagnosed with hemophilia A (symptomatic carrier) and hypermobility syndrome – a connective tissue disorder meaning my joints stretch further than normal. Aminocaproic acid (Amicar®) was prescribed for mucosal bleeding and clotting factor for muscle and joint bleeds. An emergency medical card was prepared with my treater’s name, contact number and diagnosis. A medical alert bracelet was ordered for me, and I was instructed to contact the treatment center and treat on-demand as needed.

Imagine my delight to find when I treated a bleed as my hematologist instructed, my whole body felt better; things that had hurt my entire life stopped hurting; my petechiae cleared, and the swelling in my knees and ankles subsided. Then, as the factor left my body, the pain and baffling bruising would return.

I was able to access treatment from the out-of-state HTC for a short time, and I was emboldened to treat my hemophilia the same way I was as a mother in treating Nicholas’ hemophilia. Since I had been infusing him for years, infusing myself was easy, and I kept a log of bleeds and treatments. I was amazed at the overall improvement in my energy and stamina when using factor!

Moving forward to 2022 – Through my out-of-state HTC, I was able to access free trials of factor products, but those have ended. I am no longer able to have treatment for my bleeds. The system that pays for factor for persons with bleeding disorders requires an in-state doctor to write the prescription. So far, I have not found a doctor in my state who is knowledgeable about the particular genetic mutation that causes me to have a high factor level yet bleed severely. I am now a woman without a treatment center and without treatment.

My chronic pain and suffering affects not only me, but my family as well. Because of my health, we are not living our best life. In spite of this, I am grateful for my experiences, to my sons born with hemophilia, and to Anthony who didn’t survive due to the lack of knowledge that prevails to this very day. This lack prevents his mother from treatment and medication.

I am grateful to Nicholas, who bears witness to the stark contrast of gender care in hemophilia. I have built a career advocating for those like me who are unable to access the care we know is needed. I am appreciative for all of these experiences, but I would also like to be grateful for access to treatment for all women with hemophilia. It is my hope this will be a reality soon.


TIMELINE HIGHLIGHTING A FEW SYMPTOMS THROUGH THE YEARS:

  • Age 4: my first memory of severe pain in my knees. I had no words to describe the pain and it went unattended.

  • Age 9: moved to a home in a hilly area. I had pain that brought tears and immobility. Diagnosed with pre-patellar chondromalacia and was instructed to avoid hills and stairs, and to rest, ice and elevate. The constant pain kept me sedentary.

  • Age 10: my menstrual cycle began with extreme pain, heavy clots, bruises under my eyes and sheer exhaustion. Soaked through sanitary pads and ruined sheets. At school, it seemed I was in the bathroom more than in class. Treatment for this would never come. I spent my menstruating years suffering the effects of anemia.

  • Age 15: cut my ankle on a jagged piece of wood. The wound kept oozing and reopening, taking a year to fully heal.

  • Age 16: worked long shifts standing on a hard restaurant floor, in constant pain, fatigued, with swollen knees and ankles. When sitting, I would draw my legs up under my body to prevent my ankles from dangling as the pain was unbearable. Tired and hurting all the time. By the time I became sexually active, I bled with intercourse regardless of my cycle.

  • Age 21: diagnosed with gout in my toe. I now recognize this was a bleed.

  • Age 25+: with each of my first 3 pregnancies, I experienced anemia, 2nd trimester spotting, petechial hemorrhaging around my face during childbirth and prolonged postpartum bleeding. 2nd pregnancy brought throbbing pain behind my left eye leading to a spinal tap that would not clot causing a week-long leak of cerebrospinal fluid. 3rd pregnancy resulted in prolonged healing of c-section incision.

  • Age 27: wisdom teeth extraction bled for weeks.

  • Age 28: at the ER with excruciating knee pain. Was told there was nothing to be done.

  • Age 32: sons Anthony and Nicholas were born via C-section. A bleed at the incision caused excruciating pain; bleeding and severe bruising in my groin and down my legs.

  • Age 35: diagnosed with fibromyalgia.

  • Age 45: diagnosed with tendinosis (Related to connective tissue disorder).

  • Age 53: finally diagnosed as a symptomatic carrier of hemophilia A and connective tissue disorder reaffirmed. Was prescribed factor, Amicar® and physical therapy.

  • Age 56: free factor trials end; I no longer have access to treatment.


Stay informed on the latest trends in healthcare and specialty pharmacy.

Sign up for our monthly e-newsletter, BioMatrix Abstract.

By giving us your contact information and signing up to receive this content, you'll also be receiving marketing materials by email. You can unsubscribe at any time. We value your privacy. Our mailing list is private and will never be sold or shared with a third party. Review our Privacy Policy here.


Similarities, Differences, and Correlations Between Allergies, Common Variable Immunodeficiency (CVID), and Autoimmune Disorders


Allergies, common variable immunodeficiency (CVID), and autoimmune disorders all share similarities and can commonly be mistaken for one another. This article explores those similarities as well as major differences, evidence for potential links, and treatment options.


What is common variable immune deficiency (CVID)?

Let’s first take a look at common variable immunodeficiency (CVID). Characterized by low levels of serum immunoglobulins and antibodies, CVID is a form of primary immunodeficiency—meaning the immune system is deficient in what it needs to fight infection which therefore causes an increased susceptibility to infection. Those with CVID often develop recurring infection in the lungs, sinuses, and ears. The exact cause of CVID is unknown, though genetic defects may play a role.1


What are allergies and how are they related to autoimmune disorders and CVID?

An allergy occurs when your immune system reacts to a foreign substance that is typically not harmful to other people—i.e. pollen or pet dander. Both an allergic reaction and an autoimmune response happen when your body tries to expel a foreign substance. The difference is that with an allergic response, the foreign substance is an allergen (again, typically harmless to most people) while with an autoimmune response, the foreign substance is indeed harmful—i.e. a virus, parasite, or bacteria. Steve Ziegler, PhD, Director of the Immunology Research Program at Benaroya Research Institute states that “In autoimmunity, there is a different type of T-cell involved than in allergies. In an autoimmune response, tissue destruction occurs. With allergies, the immune system overreacts to harmless allergens. Interestingly, this is the same type of response that expels viruses, parasites, and bacteria from the body.”2

It’s important to note that CVID is not an autoimmune disorder. Autoimmune disorders occur when your immune system can’t tell the difference between foreign cells (like bacteria and viruses) and your own cells. Because of this, your immune system will attack healthy cells in your body in addition to unhealthy foreign cells. CVID, on the other hand, occurs when your body has existing low levels of antibodies.


Is there a link between CVID, autoimmune disorders, and allergies?

With 25% of CVID patients having an autoimmune disorder3, there seems to be a positive correlation between CVID and autoimmune disorders. Research has demonstrated that those with defects in their immune system (like having lower amounts of antibodies) carry a high risk for the development of autoimmune disease.4 When compared to the general population, CVID patients also have a greater risk for granulomata (a mass of granulation tissue), tumors, and an increased susceptibility to cancer.1 In a 2021 study, allergic-like disorders and autoimmunity were diagnosed in 41.3% of CVID subjects.5 Though further testing was needed to determine the cause, in a 2009 study, 86.1% of participating CVID patients had rhinosinusitis (inflammation of the nasal cavity and paranasal sinuses).6 With these findings, though a possible link seems likely to exist between these three conditions, researches are still trying to figure out why exactly these conditions occur in the first place. This could lead to finding further causes for these positive correlations as well as even more effective, targeted treatment options.


Treatment

Treatment for allergies and autoimmune conditions varies greatly depending on the type and severity. An allergy treatment plan may involve avoiding allergens, medicine, and/or immunotherapy.7 An autoimmune treatment plan may involve a wide range of therapies—from anti-inflammatory medication to IG treatment.8 CVID is typically treated with immunoglobulin (IG) (subcutaneous) infusions—especially for those with substantial decreased IG production and nonresponse to both protein and polysaccharide vaccines.9 The IG therapy provides antibodies from the blood of healthy donors. Other problems caused by CVID, like bacterial infections, may require additional, tailored treatments.10

Our team has extensive experience with IG related support services. As a national provider of IG, BioMatrix has broad access to leading brands and inventory. Our IG treatment plans are designed to:

  • Prevent infections
  • Boost the immune system
  • Avoid complications of therapy
  • Prevent long-term organ damage
  • Decrease hospitalizations
  • Encourage patients to participate in disease management
  • Prolong life
  • Improve general health and quality of life

Our nursing team coordinates the best site of care for scheduled infusions—whether in the patient’s home or physician’s office. Providing site-of-care options offers convenience for patients and cost savings to insurance providers.

Together, our clinicians, support staff, and digital health technology offer a comprehensive approach improving quality of life for patients and producing positive outcomes along the entire healthcare continuum.


DISCLAIMER: THIS IS NOT MEDICAL ADVICE. All information, content, and material is for informational purposes only and is not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider. Please consult a physician or other health care professional for your specific health care and/or medical needs or concerns and never disregard professional medical advice or delay in seeking it because of something you have read here or on our website.


Stay informed on the latest trends in healthcare and specialty pharmacy.

Sign up for our monthly e-newsletter, BioMatrix Abstract.

By giving us your contact information and signing up to receive this content, you'll also be receiving marketing materials by email. You can unsubscribe at any time. We value your privacy. Our mailing list is private and will never be sold or shared with a third party. Review our Privacy Policy here.

References

  1. Overview of Common Variable Immune Deficiency. Immune Deficiency Foundation. https://primaryimmune.org/about-primary-immunodeficiencies/specific-disease-types/common-variable-immune-deficiency

  2. (2017). Connecting the Dots Between Allergies and Autoimmune Disease. Benaroya Research Institute. https://www.benaroyaresearch.org/blog/post/connecting-dots-between-allergies-and-autoimmune-disease

  3. Common Variable Immune Deficiency. MedlinePlus. https://medlineplus.gov/genetics/condition/common-variable-immune-deficiency

  4. Sleasman J. W. (1996). The association between immunodeficiency and the development of autoimmune disease. Advances in dental research, 10(1), 57–61. https://doi.org/10.1177/08959374960100011101

  5. Rubin, L., Shamriz, O., Toker, O., Kadish, E., Ribak, Y., Talmon, A., Hershko, A. Y., & Tal, Y. (2022). Allergic-like disorders and asthma in patients with common variable immunodeficiency: a multi-center experience. The Journal of asthma : official journal of the Association for the Care of Asthma, 59(3), 476–483. https://doi.org/10.1080/02770903.2020.1862185

  6. Agondi, R. C., Barros, M. T., Kokron, C. M., Cohon, A., Oliveira, A. K., Kalil, J., & Giavina-Bianchi, P. (2013). Can patients with common variable immunodeficiency have allergic rhinitis?. American journal of rhinology & allergy, 27(2), 79–83. https://doi.org/10.2500/ajra.2013.27.3855

  7. (2018). What Are the Best Treatments for Allergies? Asthma and Allergy Foundation of America. https://aafa.org/allergies/allergy-treatments/

  8. (2021). Autoimmune Diseases. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/21624-autoimmune-diseases

  9. Cunningham-Rundles C. Treatment And Prognosis Of Common Variable Immunodeficiency. (https://www.uptodate.com/contents/treatment-and-prognosis-of-common-variable-immunodeficiency

  10. (2019). Common Variable Immunodeficiency (CVID). National Institute of Allergy and Infectious Diseases. https://www.niaid.nih.gov/diseases-conditions/common-variable-immunodeficiency-cvid

New Hemophilia Classifications For Women

By David Clark, Ph.D.


We now recognize women can also have hemophilia, and it is imperative to define diagnostic criteria that apply to them. This is needed for insurance coverage of their treatment as well as their own recognition and self-respect. Imagine if you had to limp around on your damaged joints from doctor to doctor to find one to take you seriously. Too many women in our community have had just that experience. Now, we can give names to their conditions.


An international group of twelve hemophilia treaters and patient advocates has taken on this project under the Scientific and Standardization Committee (SSC) of the International Society on Thrombosis and Haemostasis (ISTH). The project was mainly supported by the NHF, HFA, and the Coalition for Hemophilia B from the U.S., as well as other hemophilia organizations around the world. There was no commercial support. The results were published in an article in the Journal of Thrombosis and Haemostasis on July 31, 2021. [See the complete citation at the end of this article.]

The results are shown in the table below. The same classifications are used for both hemophilia A and B. For factor levels up to 40%, women receive exactly the same diagnoses as their male counterparts. They are classified as severe/moderate/mild based on their factor levels. Above 40%, the tables turn. Men with factor levels above 40% are not considered to have hemophilia in many countries. However, women who are carriers with factor levels above 40% can still have a bleeding diagnosis.

The first thing to recognize is that the term “carrier” is now being returned to its proper definition. Carrier is a genetic description – it does not define a bleeding disorder. A woman is a carrier because she carries a mutated factor VIII or IX gene on her X chromosome that she can pass on to her offspring. She may or may not have a bleeding disorder. Carriers can have normal levels of factor VIII or IX.

Next, we need to discuss the international standard of 40% upper limit for hemophilia. In the U.S., we commonly use 50% as the upper limit for hemophilia and the lower limit for the range of normal factor levels. We recognize men with clotting levels up to 50% may still have mild hemophilia and may need treatment. In the rest of the world, men with levels of 40 – 50% are not considered to have hemophilia.

This gets more complicated because we know women can bleed even at levels up to 60%. We don’t know why they still bleed, but the study’s authors have recognized this and have given women two more categories. If a carrier has a level above 40% and does not have bleeding symptoms, she is classified as an “asymptomatic carrier.” However, if a carrier has a factor VIII or IX level over 40% (with no upper limit) but still has bleeding symptoms, she is classified as a “symptomatic carrier.”

This fuzziness in the over 40% levels could lead to situations where it is now the men who could have trouble getting treated. Going by the international classification, a man with a 50% factor VIII or IX level would not be considered to have mild hemophilia, even if he has bleeding symptoms. Yet, if he were a woman with a 50% level and bleeding symptoms, she would be a symptomatic carrier who might have a better chance of being treated. 

In addition, all of the categories are just approximations. It is the best we can do with our current state of knowledge. We know that about 15% of people (men and women) do not bleed according to their category of mild, moderate or severe, as determined by their factor level. For instance, some people classified as severe bleed like moderates. Some people classified as mild bleed much more heavily.

Another term seen is obligate carrier. This is also a genetic description, not a bleeding diagnosis. If you are genetically female (have two X chromosomes) and your father has/had hemophilia, you are an obligate carrier. That means you carry (have inherited) your father’s mutated factor VIII or IX gene. That’s just how genetics works. You may or may not bleed. Of course, the genetics can always mess up – that’s how we get hemophilia in the first place. However, it is extremely unlikely that when your father passes along his mutated factor VIII or IX gene, there is another mutation that actually fixes the gene.

One interesting point in the article is the estimate that for every male with hemophilia, there are 1.6 female carriers. Since many of these female carriers might have bleeding problems, there may actually be more women with hemophilia than men. Tell that to your doctor who says women don’t get hemophilia!

This is all based on averages, and no one is average! That’s why you always have to talk to your doctor about your individual case. No one should bleed, no matter their factor levels.


ABOUT THE AUTHOR

David Clark, PhD. is an independent consultant to the biotechnology, plasma, and tissue industries. He has 35+ years of experience in the development and manufacturing of plasma and tissue products, including factor VIII and factor IX concentrates, primarily with the American Red Cross. Dr. Clark holds a Ph.D. in chemical engineering from Cornell University.


REFERENCE

van Galen Karin PM, et al., A New Hemophilia Carrier Nomenclature to Define Hemophilia in Women and Girls: Communication from the SSC of the ISTH, Journal of Thrombosis and Haemostasis, 19(8), 1883-1887, 2021. https://pubmed.ncbi.nlm.nih.gov/34327828/


Stay informed on the latest trends in healthcare and specialty pharmacy.

Sign up for our monthly e-newsletter, BioMatrix Abstract.

By giving us your contact information and signing up to receive this content, you'll also be receiving marketing materials by email. You can unsubscribe at any time. We value your privacy. Our mailing list is private and will never be sold or shared with a third party. Review our Privacy Policy here.


Home Infusion: The Importance of Qualified, Home Nursing Services


The benefits of home health care, specifically home infusion, are substantial. With home infusion, patients can receive their medication in the safety and comfort of their own home by a clinically-trained infusion nurse. Benefits include safety, convenience, cost-savings, and patient well being. Here we discuss how our nursing team supports treatment success for patients when and where they need it most.


Extensive Vetting and Training

In addition to our highly-qualified internal nurse clinicians, BioMatrix has contracted with over 200 nursing agencies nationwide and are continually bringing new agencies into the fold. Per our rigorous standards, each agency is thoroughly vetted to make sure they are knowledgeable regarding the Infusion Nurses Society guidelines for infusion therapy in the home. 

Just as the nursing agencies we contract with are thoroughly vetted, so too are the individual home infusion nurses. Every home infusion nurse assigned to enter a patient’s home is required to meet (over the phone or virtually) with our nurse clinicians prior to providing service. Our nurse clinicians:

  • Evaluate the infusion RN’s level of competency to provide the care ordered. If needed, further education or training is arranged and completed before the start of care. 

  • Review prescribed therapy in detail with the home infusion nurse to make sure the appropriate protocols are followed, and the services provided are safe and seamless. 

Every nurse who enters a patient’s home is carefully determined ensuring a right fit for the patient, their condition, and individual treatment need. If at any time our nurse clinicians determine that a particular home infusion nurse does not meet the standard of competency that we at BioMatrix strive for, we re-group, and re-staff the case with an alternate home infusion nurse.


Site-of-Care Coordination

We are well aware of how important it is for patients to avoid conflicts with work and other obligations. Our nurse clinicians strive to come up with a plan for infusions that causes the least disruption as possible for the patient while staying within the parameters that their MD has ordered. Whether administering in-home with assistance from one of our home care nurses, in-office, or at our Ambulatory Infusion Center, our nurses work with patients and prescribers to make therapy administration as safe and convenient as possible.


Safety Protocols

All BioMatrix nurse professionals follow CDC guidelines for hygiene and germ reduction and help patients mitigate any issues to establish a safe environment for home infusion. When entering a patient’s home, the home infusion nurses we work with follow all standard precautions and wear appropriate personal protective equipment. They also take the time to identify and review safety measures the patient can follow in the home both during and after infusion. 


Clinical Interventions

Following each home infusion, the home infusion nurse will submit a report to the BioMatrix clinical team to track response to therapy, monitor for adverse events, and help personalize and improve future care. By synthesizing clinical, social, and drug utilization information, our nursing team’s actionable interventions help improve health and save lives. Our interventions support patient adherence to therapy, reduce side-effects, and help address both critical and every day issues related to life with a chronic health condition.


Patient Education

We understand that starting a new therapy and navigating the treatment process can be challenging and confusing for a patient. Where appropriate, our nursing team provides self-administration training for injectable or infusible drugs, allowing patients to more independently manage their condition. Our nurses can also guide patients post administration to maintain therapy adherence, minimize or manage side-effects, and answer questions that may arise throughout their treatment regimen.


The BioMatrix clinical team includes compassionate nurses who have extensive training and experience with rare diseases, infusion therapies, and complex medical conditions.

Our nurses work together with patients, caregivers, pharmacists, and prescribers to coordinate the optimal site of care, conduct nursing interventions, and provide patient education.


Watch our video here to learn more about our home infusion services.


Stay informed on the latest trends in healthcare and specialty pharmacy.

Sign up for our monthly e-newsletter, BioMatrix Abstract.

By giving us your contact information and signing up to receive this content, you'll also be receiving marketing materials by email. You can unsubscribe at any time. We value your privacy. Our mailing list is private and will never be sold or shared with a third party. Review our Privacy Policy here.


References

1. Le Masson G, Solé G, Desnuelle C, et al. (2018). Home versus hospital immunoglobulin treatment for autoimmune neuropathies: a cost minimization analysis. Brain Behav. 2018;8(2):e00923. doi: 10.1002/brb3.923

2. Luthra R, Quimbo R, Iyer R, Luo M. (2014). An analysis of intravenous immunoglobin site of care: home versus outpatient hospital. Am J Pharm Benefits. 2014;6(2):e41-e49.

3. Schmidt R. (2012). Home Infusion Therapy: Safety, Efficacy, and Cost-Savings. PSQH. https://www.psqh.com/analysis/home-infusion-therapy-safety-efficacy-and-cost-savings/

4. Polinski J, Kowal M, Gagnon M, Brennan T, Shrank W. (2016). Home infusion: Safe, clinically effective, patient preferred, and cost saving. NIH. https://pubmed.ncbi.nlm.nih.gov/28668202/

5. Home Infusion Creates Savings for Patients, Taxpayers. NHIA. https://nhia.org/wp-content/uploads/2020/03/Home_Infusion_Creates_Savings_for_Patients_Taxpayers.pdf